Other Species / Isoforms
  SUMO3 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S2-p
______MsEEkPkEG
0 2
SUMO3 (human) ______MsEEkPkEG S2-p
SUMO3 (mouse) ______MsEEKPKEG S2-p
SUMO3 (rat) ______MSEEkPkEG S2
K5
___MsEEKPkEGVkt
0 1
SUMO3 (human) ___MsEEKPkEGVkt K5
SUMO3 (mouse) ___MsEEKPKEGVkt K5
SUMO3 (rat) ___MSEEkPkEGVkT K5-ac
K5-ub
___MsEEkPkEGVkt
0 2
SUMO3 (human) ___MsEEkPkEGVkt K5-ub
SUMO3 (mouse) ___MsEEKPKEGVkt K5
SUMO3 (rat) ___MSEEKPkEGVkT K5
K7
_MsEEkPKEGVktEN
0 1
SUMO3 (human) _MsEEkPKEGVktEN K7
SUMO3 (mouse) _MsEEKPKEGVktEN K7
SUMO3 (rat) _MSEEkPkEGVkTEN K7-ac
K7-ub
_MsEEkPkEGVktEN
0 4
SUMO3 (human) _MsEEkPkEGVktEN K7-ub
SUMO3 (mouse) _MsEEKPKEGVktEN K7
SUMO3 (rat) _MSEEkPKEGVkTEN K7
K7-sm
_MsEEkPkEGVktEN
0 1
SUMO3 (human) _MsEEkPkEGVktEN K7-sm
SUMO3 (mouse) _MsEEKPKEGVktEN K7
SUMO3 (rat) _MSEEkPKEGVkTEN K7
K11-ac
EkPkEGVktENDHIN
0 3
SUMO3 (human) EkPkEGVktENDHIN K11-ac
SUMO3 (mouse) EKPKEGVKtENDHIN K11
SUMO3 (rat) EkPkEGVkTENDHIN K11-ac
K11-ub
EkPkEGVktENDHIN
0 9
SUMO3 (human) EkPkEGVktENDHIN K11-ub
SUMO3 (mouse) EKPKEGVktENDHIN K11-ub
SUMO3 (rat) EkPkEGVKTENDHIN K11
K11-sm
EkPkEGVktENDHIN
Upstream
4 5
Treatment
  • heat_shock
SUMO3 (human) EkPkEGVktENDHIN K11-sm
SUMO3 (mouse) EKPKEGVKtENDHIN K11
SUMO3 (rat) EkPkEGVKTENDHIN K11
T12-p
kPkEGVktENDHINL
0 2
SUMO3 (human) kPkEGVktENDHINL T12-p
SUMO3 (mouse) KPKEGVktENDHINL T12-p
SUMO3 (rat) kPkEGVkTENDHINL T12
K20-ub
ENDHINLkVAGQDGs
1 4
SUMO3 (human) ENDHINLkVAGQDGs K20-ub
SUMO3 (mouse) ENDHINLKVAGQDGs K20
SUMO3 (rat) ENDHINLKVAGQDGS K20
S27-p
kVAGQDGsVVQFkIk
0 12
SUMO3 (human) kVAGQDGsVVQFkIk S27-p
SUMO3 (mouse) KVAGQDGsVVQFkIk S27-p
SUMO3 (rat) KVAGQDGSVVQFkIK S27
K32-ac
DGsVVQFkIkRHtPL
0 5
SUMO3 (human) DGsVVQFkIkRHtPL K32-ac
SUMO3 (mouse) DGsVVQFKIkRHtPL K32
SUMO3 (rat) DGSVVQFkIKRHTPL K32-ac
K32-ub
DGsVVQFkIkRHtPL
2 33
SUMO3 (human) DGsVVQFkIkRHtPL K32-ub
SUMO3 (mouse) DGsVVQFkIkRHtPL K32-ub
SUMO3 (rat) DGSVVQFKIKRHTPL K32
K34-ub
sVVQFkIkRHtPLSk
0 12
SUMO3 (human) sVVQFkIkRHtPLSk K34-ub
SUMO3 (mouse) sVVQFkIkRHtPLSk K34-ub
SUMO3 (rat) SVVQFkIKRHTPLSk K34
T37-p
QFkIkRHtPLSkLMk
Upstream
0 6
Treatment
  • nocodazole
SUMO3 (human) QFkIkRHtPLSkLMk T37-p
SUMO3 (mouse) QFkIkRHtPLSkLMk T37-p
SUMO3 (rat) QFkIKRHTPLSkLMk T37
K41-ac
kRHtPLSkLMkAYCE
0 12
SUMO3 (human) kRHtPLSkLMkAYCE K41-ac
SUMO3 (mouse) kRHtPLSKLMkAYCE K41
SUMO3 (rat) KRHTPLSkLMkAYCE K41-ac
K41-ub
kRHtPLSkLMkAYCE
0 54
SUMO3 (human) kRHtPLSkLMkAYCE K41-ub
SUMO3 (mouse) kRHtPLSkLMkAYCE K41-ub
SUMO3 (rat) KRHTPLSkLMkAYCE K41-ub
K41-sm
kRHtPLSkLMkAYCE
1 1
SUMO3 (human) kRHtPLSkLMkAYCE K41-sm
SUMO3 (mouse) kRHtPLSKLMkAYCE K41
SUMO3 (rat) KRHTPLSKLMkAYCE K41
K44-ac
tPLSkLMkAYCERQG
0 3
SUMO3 (human) tPLSkLMkAYCERQG K44-ac
SUMO3 (mouse) tPLSkLMKAYCERQG K44
SUMO3 (rat) TPLSkLMkAYCERQG K44-ac
K44-ub
tPLSkLMkAYCERQG
0 53
SUMO3 (human) tPLSkLMkAYCERQG K44-ub
SUMO3 (mouse) tPLSkLMkAYCERQG K44-ub
SUMO3 (rat) TPLSkLMkAYCERQG K44-ub
S53-p
YCERQGLsMRQIRFR
0 6
SUMO3 (human) YCERQGLsMRQIRFR S53-p
SUMO3 (mouse) YCERQGLSMRQIRFR S53
SUMO3 (rat) YCERQGLSMRQIRFR S53